Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleNIAID amps up vaccine adjuvant work.AuthorsMullard, AsherAbstractThe article reports on the plan of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) to spend up to $70 million for the development of vaccine adjuvants.SubjectsDRUG development; IMMUNOLOGICAL adjuvants; NATIONAL Institute of Allergy &; Infectious Diseases (U.S.); FINANCEPublicationNature Reviews Drug Discovery, 2014, Vol 13, Issue 11, p803ISSN1474-1776Publication typeArticleDOI10.1038/nrd4485